Kairos Biotech is an early stage company focusing on proprietary small molecule discovery applied to diagnostics and immunotherapy.  Our initial focus is on improving transplant outcomes by removing immunological barriers to transplantation.

   


Molecules that have potential diagnostic ability in cellular and immunoassays are identified in our proprietary discovery process. 

Selected molecules that show promise can be used in determining donor specific alloreactivity in diagnostic applications.

Further modification of these molecules generates the potential for them to be used as specific and potent immunosupression.

---

Images by Freepik    www.freepik.com